The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular...

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) involves structural brain changes and cerebrovascular lesions.
• Shared pathological factors between AD and vascular injury are under investigation.
• The role of ubiquitin C-terminal hydrolase L1 (Uch-L1) in AD pathogenesis is unclear.

Purpose of the Study:

• To investigate the shared factors between Alzheimer's disease (AD) and cerebrovascular lesions.
• To elucidate the role of ubiquitin C-terminal hydrolase L1 (Uch-L1) in AD pathogenesis and its link to BACE1.
• To explore Uch-L1 modulation as a potential therapeutic strategy for AD.

Main Methods:

• Utilized a transgenic AD mouse model and control mice subjected to photo-activated cortical infarction.
• Assessed the effects of Uch-L1 inhibition and restoration on BACE1 levels, neuronal cell death, and NF-κB activation.
• Employed Bengal Rose dye for light-induced cortical infarction to model vascular injury.

Main Results:

• Uch-L1 inhibition led to increased BACE1 expression, neuronal apoptosis, and NF-κB activation in both control and AD models.
• Restoration of Uch-L1 activity prevented BACE1 up-regulation and reduced neuronal cell death.
• These findings highlight a mechanism linking Uch-L1 to BACE1 and Aβ peptide accumulation in vascular injury.

Conclusions:

• Uch-L1 plays a critical role in regulating BACE1, impacting neuronal cell death and potentially Aβ accumulation.
• Modulating Uch-L1 activity offers a promising therapeutic avenue for Alzheimer's disease and associated vascular pathologies.
• Targeting Uch-L1 may provide novel strategies to combat the dual pathologies observed in affected patients.